Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors [Phase 1]
A Phase 1 clinical trial is evaluating expanded multi-antigen specific lymphocytes for solid tumors. The trial is actively not recruiting an…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Study of CHS-114 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating CHS-114 in participants with advanced solid tumors, including head and neck squamous cell carcinoma; currently recr…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology [NA]
A clinical trial update describes a study on nurse-initiated conversations to support early integration of palliative care in pediatric onco…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification [Phase 1]
BeiGene is conducting a first-in-human Phase 1 study of BGB-53038, a pan-KRAS inhibitor, as a monotherapy or in combination, in participants…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors [Phase 1]
A first-in-human Phase 1 study to evaluate the safety and tolerability of VVD-130037 in participants with advanced solid tumors. The trial i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor [Phase 1]
Phase I study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of HLX97, a KAT6A/B inhibitor, in patients with adv…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors [Phase 1, Phase 2]
Roche is conducting a dose-escalation Phase 1/2 trial of a PD-1/LAG-3 bispecific antibody in patients with advanced or metastatic solid tumo…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors [Phase 1, Phase 2]
A pediatric Phase 1/2 trial evaluating nivolumab in combination with metronomic chemotherapy for refractory/relapsing solid tumors; the stud…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors [Phase 1]
A first-in-human Phase 1 study to evaluate the safety and tolerability of VVD-159642 in participants with solid tumors; recruitment is ongoi…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating KK2260 in patients with advanced or metastatic solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers [Phase 1, Phase 2]
A clinical trial update describing STK-012 alone or in combination for advanced lung cancer and other solid tumors, currently recruiting in …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors [Phase 1]
Open-label Phase 1 trial evaluating INV-1120 as a single agent and in combination with pembrolizumab in adults with advanced solid tumors; c…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: CSF and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and CNS Metastases or no CNS Metastases [NA]
A clinical trial evaluating CSF and blood plasma liquid biopsy in patients with metastatic solid tumors, with and without brain metastases o…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Exploration Study of Molecular Biomarkers for Tumor-related Anxiety and Depression
A clinical trial exploring molecular biomarkers associated with tumor-related anxiety and depression in patients with solid tumor malignanci…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports that GI Innovation is studying GI-101 and GI-101A as single agents or in combination with pembrolizumab o…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating ETX-636 in adults with advanced solid tumors and advanced breast cancer; currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients [Phase 1, Phase 2]
An ongoing phase 1/2 pediatric trial examines safety and potential efficacy of a four-drug combination (cyclophosphamide, sorafenib, bevaciz…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Standardized Nutritional Management of Pediatric Patients With Solid Tumors [NA]
This clinical trial examines standardized nutritional management for pediatric patients with solid tumors. The study is currently recruiting…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Predicting Reactions and Effects of Drugs Immunotherapy and Complications Through Oncosafety (PREDICTO Clinical Study) [NA]
This entry describes the PREDICTO clinical study aimed at predicting reactions and complications from cancer immunotherapy, sponsored by Ass…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Reduced Intensity Haploidentical BMT for High Risk Solid Tumors [Phase 2]
Phase 2 trial investigating reduced-intensity haploidentical bone marrow transplantation for high-risk metastatic solid tumors; the study st…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors [Phase 1]
A Phase 1 study of D3L-001 as monotherapy in HER2-positive advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001) [Phase 1]
A Phase 1 study (MK-0472-001) of MK-0472 in participants with advanced or metastatic solid tumors; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses [NA]
This clinical trial update describes a program to help patients and spouses understand and manage the financial aspects of cancer care. The …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation. [Phase 1]
Phase 1 clinical trial to assess the pharmacokinetic interactions of multiple doses of rezatapopt with metformin, rosuvastatin, repaglinide,…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation [Phase 1, Phase 2]
A Phase 1/2 study of D3S-001 as a monotherapy or combination therapy in advanced solid tumors with KRAS p.G12C mutation is currently recruit…